4lkc: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{STRUCTURE_4lkc| PDB=4lkc | SCENE= }} | {{STRUCTURE_4lkc| PDB=4lkc | SCENE= }} | ||
===An Antibody Against the C-terminal Domain of PCSK9 lowers LDL Cholesterol Levels in vivo=== | ===An Antibody Against the C-terminal Domain of PCSK9 lowers LDL Cholesterol Levels in vivo=== | ||
{{ABSTRACT_PUBMED_24252255}} | |||
==About this Structure== | ==About this Structure== | ||
[[4lkc]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/ | [[4lkc]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4LKC OCA]. | ||
[[Category: | |||
==Reference== | |||
<ref group="xtra">PMID:024252255</ref><references group="xtra"/><references/> | |||
[[Category: Human]] | |||
[[Category: Nar, H.]] | [[Category: Nar, H.]] | ||
[[Category: Schiele, F.]] | [[Category: Schiele, F.]] | ||
Revision as of 08:50, 4 December 2013
An Antibody Against the C-terminal Domain of PCSK9 lowers LDL Cholesterol Levels in vivoAn Antibody Against the C-terminal Domain of PCSK9 lowers LDL Cholesterol Levels in vivo
Template:ABSTRACT PUBMED 24252255
About this StructureAbout this Structure
4lkc is a 2 chain structure with sequence from Human. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Schiele F, Park J, Redemann N, Luippold G, Nar H. An Antibody against the C-Terminal Domain of PCSK9 Lowers LDL Cholesterol Levels InVivo. J Mol Biol. 2013 Nov 16. pii: S0022-2836(13)00722-5. doi:, 10.1016/j.jmb.2013.11.011. PMID:24252255 doi:http://dx.doi.org/10.1016/j.jmb.2013.11.011